KYTX
Kyverna Therapeutics, Inc.
7.00$
-1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -21.7% | +12.4% | +305.1% | -3.6% | |
| – | -30.9% | +13.9% | +379.0% | -2.6% | |
| – | -50.4% | -8.2% | +178.9% | +28.4% | |
| – | -32.5% | +12.1% | +397.0% | -2.4% | |
| – | +7.0% | -81.5% | +46.3% | +61.7% | |
| – | -24.9% | +66.1% | +70.0% | +8.1% | |
| – | +179.7% | +28.2% | +34.9% | +0.7% | |
| – | +87.7% | +200.3% | +6.1% | +14.7% | |
| – | – | – | – | – | |
| – | – | – | +442.1% | -12.9% | |
| – | – | – | – | – | |
| – | +0.0% | +2,510.5% | -94.3% | +15.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.